These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6366244)

  • 1. Confirmation of EMIT cannabinoid assay results by bonded phase adsorption with thin layer chromatography.
    Willson NJ; Kogan MJ; Pierson DJ; Newman E
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):465-73. PubMed ID: 6366244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine cannabinoid analysis: an integrated multi-method approach.
    Black DL; Goldberger BA; Isenschmid DS; White SM; Caplan YH
    J Anal Toxicol; 1984; 8(5):224-7. PubMed ID: 6389979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One hundred EMIT positive cannabinoid urine samples confirmed by BPA/TLC, RIA, and GC/MS.
    Verebey K; Mulé SJ; Alrazi J; Lehrer M
    J Anal Toxicol; 1986; 10(2):79-80. PubMed ID: 3517489
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzyme immunochemical detection of the use of hashish and confirmation by thin-layer chromatography].
    von Meyer L
    Z Rechtsmed; 1985; 94(3):219-25. PubMed ID: 2992188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and confirmation of urinary cannabinoids.
    Sutheimer CA; Yarborough R; Hepler BR; Sunshine I
    J Anal Toxicol; 1985; 9(4):156-60. PubMed ID: 4033071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of six cannabinoid metabolite assays.
    Frederick DL; Green J; Fowler MW
    J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in urine using thin-layer chromatography].
    Nováková E
    Soud Lek; 1997 Feb; 42(1):5-8. PubMed ID: 9221514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative high performance thin layer chromatography (HPTLC) analysis of cannabinoids in urine samples of Cannabis abusers.
    Sharma P; Bharath MM; Murthy P
    Indian J Med Res; 2010 Aug; 132():201-8. PubMed ID: 20716821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of EMIT-dau Benzodiazepine Metabolite Assay for urine drug screening.
    Poklis A
    J Anal Toxicol; 1981; 5(4):174-6. PubMed ID: 7024639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cannabinoids in monitoring abstinence in a drug abuse treatment program.
    Schwartz RH; Willette RE; Hayden GF; Bogema S; Thorne MM; Hicks J
    Arch Pathol Lab Med; 1987 Aug; 111(8):708-11. PubMed ID: 3307687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug screening by enzyme immunoassay (EMIT) and thin-layer chromatography (Drug Skreen).
    Oellerich M; Külpmann WR; Haeckel R
    J Clin Chem Clin Biochem; 1977 May; 15(5):275-83. PubMed ID: 330794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme immunoassay method for comprehensive drug screening in micro-samples of urine.
    Black DL; Goldberger BA; Caplan YH
    Clin Chem; 1987 Mar; 33(3):367-71. PubMed ID: 3545536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of the TDx assay for detection of cannabinoids in urine from prison inmates.
    Karlsson L; Ström M
    J Anal Toxicol; 1988; 12(6):319-21. PubMed ID: 3072448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneous enzyme immunoassay for cannabinoids in urine.
    Rodgers R; Crowl CP; Eimstad WM; Hu MW; Kam JK; Ronald RC; Rowley GL; Ullman EF
    Clin Chem; 1978 Jan; 24(1):95-100. PubMed ID: 338202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantitation of cannabinoids in biological fluids: specificity and kinetics after smoking.
    Scherrmann JM; Hoellinger H; Nguyen-Hoang-Nam ; Boudet L; Pichon J; Do-Cao-Thang
    Clin Toxicol; 1981 May; 18(5):565-71. PubMed ID: 6268351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of marijuana metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in human urine by bonded-phase adsorption and thin-layer chromatography.
    Kogan MJ; Newman E; Willson NJ
    J Chromatogr; 1984 Mar; 306():441-3. PubMed ID: 6325485
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results.
    Gjerde H
    Forensic Sci Int; 1991; 50(1):121-4. PubMed ID: 1657743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.